Modelled DT Structure
Method: homology modeling
Template PDB: 3J08_A
Identity: 41.168%
Minimized Score: -1415.33 kcal/mol
Detail: Structure Info
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0533 | ||||
| Gene Name | ATP7B | ||||
| Protein Name | Copper-transporting ATPase 2 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
Modelled DT Structure Method: homology modeling Template PDB: 3J08_A Identity: 41.168% Minimized Score: -1415.33 kcal/mol Detail: Structure Info |
||||
| Synonyms | ATP7B; Copper pump 2; PWD; WC1; WND; Wilson disease-associated protein | ||||
| DT Family | P-Type ATPase (P-ATPase) Superfamily ; | ||||
| Tissue Specificity | Most abundant in liver and kidney and alsofound in brain. Isoform 2 is expressed in brain but not in liver.The cleaved form WND/140 kDa is found in liver cell lines andother tissues. | ||||
| Function | This transporter involved in copper homeostasis in the liver, where it ensures the efflux of copper from hepatocytes into the bile in response to copper overload. | ||||
| Endogenous Substrate(s) | Cu+; Ag+ | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(α) Microbiota Influence of This DT |
|||||
|
(β) Post-translational Modification of This DT |
|||||
|
(γ) Transcriptional Regulation of This DT |
|||||
|
(δ) Epigenetic Regulation of This DT |
|||||
|
(ε) Exogenous Modulation of This DT |
|||||
|
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
|
(α) Mutation-induced Structural Variation |
|||||
|
(β) Inter-species Structural Differences |
|||||
|
General Variability Data of This DT (VARIDT 1.0) |
|||||
|
(α) Genetic Polymorphisms of This DT |
|||||
|
(β) Disease-specific Protein Abundances of This DT |
|||||
| Molecular Transporting Profile of This DT | |||||
|
Full List of Drug(s) Transported by This DT |
|||||
|
Approved Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
|
Cisplatin
|
Approved | Drug Info | Testicular cancer | 2C80 | [1] |
|
Endogenous Metabolites (EMs) Handled by This DT |
|||||
|
Endogenous Metabolites (EMs) |
Click to Show/Hide the Full List of EMs: 1 EMs in Total | ||||
| EM Name | PubChem CID | Detail | Experimental Material | Ref | |
| Cytoplasmic copper | EM Info | Identified using ATP7B knockout cells | [2] | ||
| References | |||||
| 1 | Effect of cisplatin on the transport activity of PII-type ATPases. Metallomics. 2017 Jul 19;9(7):960-968. | ||||
| 2 | Activation of Autophagy, Observed in Liver Tissues From Patients With Wilson Disease and From ATP7B-Deficient Animals, Protects Hepatocytes From Copper-Induced Apoptosis. Gastroenterology. 2019 Mar;156(4):1173-1189.e5. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.